These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26095510)

  • 1. Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®.
    Schlegl R; Weber M; Wruss J; Low D; Queen K; Stilwell S; Lindblad EB; Möhlen M
    Vaccine; 2015 Nov; 33(44):5989-96. PubMed ID: 26095510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51.
    Eder S; Dubischar-Kastner K; Firbas C; Jelinek T; Jilma B; Kaltenboeck A; Knappik M; Kollaritsch H; Kundi M; Paulke-Korinek M; Schuller E; Klade CS
    Vaccine; 2011 Mar; 29(14):2607-12. PubMed ID: 21288804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
    Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
    Ge FF; Qiu YF; Yang YW; Chen PY
    Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
    Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant.
    Hutcheon CJ; Becker JO; Russell BA; Bariola PA; Peterson GJ; Stroop SD
    Vaccine; 2006 Nov; 24(49-50):7214-25. PubMed ID: 16860908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
    Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP
    Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.
    Wittayanukulluk A; Jiang D; Regnier FE; Hem SL
    Vaccine; 2004 Mar; 22(9-10):1172-6. PubMed ID: 15003645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
    Hansen B; Sokolovska A; HogenEsch H; Hem SL
    Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum Hydroxide.
    Malyala P; Laera D; Cianetti S; Bufali S; Aggravi M; Ianni E; Judge C; Otten G; Singh M; O'Hagan DT
    J Pharm Sci; 2018 Jun; 107(6):1577-1585. PubMed ID: 29421216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.
    Iyer S; HogenEsch H; Hem SL
    Vaccine; 2003 Mar; 21(11-12):1219-23. PubMed ID: 12559801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoclave-Induced Changes in the Physicochemical Properties and Antigen Adsorption of Aluminum Adjuvants.
    Yu G; Yang W; Zhang N; Yang C; Zeng H; Xue C; Sun B
    J Pharm Sci; 2024 Feb; 113(2):455-462. PubMed ID: 37813301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51.
    Dubischar-Kastner K; Eder S; Buerger V; Gartner-Woelfl G; Kaltenboeck A; Schuller E; Tauber E; Klade C
    Vaccine; 2010 Jul; 28(32):5197-202. PubMed ID: 20541581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for the determination of residual formaldehyde in an inactivated Zika vaccine formulated with aluminum hydroxide gel.
    Ogasawara N; Misaki M; Adachi S
    Biologicals; 2019 Mar; 58():73-75. PubMed ID: 30660437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.